105 related articles for article (PubMed ID: 19744483)
1. Amyloid-beta fibrillogenesis: structural insight and therapeutic intervention.
Dasilva KA; Shaw JE; McLaurin J
Exp Neurol; 2010 Jun; 223(2):311-21. PubMed ID: 19744483
[TBL] [Abstract][Full Text] [Related]
2. Small molecule beta-amyloid inhibitors that stabilize protofibrillar structures in vitro improve cognition and pathology in a mouse model of Alzheimer's disease.
Hawkes CA; Deng LH; Shaw JE; Nitz M; McLaurin J
Eur J Neurosci; 2010 Jan; 31(2):203-13. PubMed ID: 20074226
[TBL] [Abstract][Full Text] [Related]
3. Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy.
Guo JP; Yu S; McGeer PL
J Alzheimers Dis; 2010; 19(4):1359-70. PubMed ID: 20061605
[TBL] [Abstract][Full Text] [Related]
4. Peptide and protein mimetics inhibiting amyloid beta-peptide aggregation.
Takahashi T; Mihara H
Acc Chem Res; 2008 Oct; 41(10):1309-18. PubMed ID: 18937396
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.
Kirkitadze MD; Condron MM; Teplow DB
J Mol Biol; 2001 Oct; 312(5):1103-19. PubMed ID: 11580253
[TBL] [Abstract][Full Text] [Related]
6. Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention.
Yang DS; Serpell LC; Yip CM; McLaurin J; Chrishti MA; Horne P; Boudreau L; Kisilevsky R; Westaway D; Fraser PE
Amyloid; 2001 Jul; 8 Suppl 1():10-9. PubMed ID: 11676284
[TBL] [Abstract][Full Text] [Related]
7. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.
Arimon M; Grimminger V; Sanz F; Lashuel HA
J Mol Biol; 2008 Dec; 384(5):1157-73. PubMed ID: 18851977
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.
McLaurin J; Franklin T; Chakrabartty A; Fraser PE
J Mol Biol; 1998 Apr; 278(1):183-94. PubMed ID: 9571042
[TBL] [Abstract][Full Text] [Related]
9. Rational design of amyloid beta peptide-binding proteins: pseudo-Abeta beta-sheet surface presented in green fluorescent protein binds tightly and preferentially to structured Abeta.
Takahashi T; Ohta K; Mihara H
Proteins; 2010 Feb; 78(2):336-47. PubMed ID: 19731370
[TBL] [Abstract][Full Text] [Related]
10. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
Davis TJ; Soto-Ortega DD; Kotarek JA; Gonzalez-Velasquez FJ; Sivakumar K; Wu L; Wang Q; Moss MA
Mol Pharmacol; 2009 Aug; 76(2):405-13. PubMed ID: 19483107
[TBL] [Abstract][Full Text] [Related]
11. Amyloid-beta aggregation.
Finder VH; Glockshuber R
Neurodegener Dis; 2007; 4(1):13-27. PubMed ID: 17429215
[TBL] [Abstract][Full Text] [Related]
12. Abeta protofibrils possess a stable core structure resistant to hydrogen exchange.
Kheterpal I; Lashuel HA; Hartley DM; Walz T; Lansbury PT; Wetzel R
Biochemistry; 2003 Dec; 42(48):14092-8. PubMed ID: 14640676
[TBL] [Abstract][Full Text] [Related]
13. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
14. Lipid membrane templates the ordering and induces the fibrillogenesis of Alzheimer's disease amyloid-beta peptide.
Chi EY; Ege C; Winans A; Majewski J; Wu G; Kjaer K; Lee KY
Proteins; 2008 Jul; 72(1):1-24. PubMed ID: 18186465
[TBL] [Abstract][Full Text] [Related]
15. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC
Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652
[TBL] [Abstract][Full Text] [Related]
16. Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.
Bakshi P; Jin C; Broutin P; Berhane B; Reed J; Mullan M
Bioorg Med Chem; 2009 Dec; 17(23):8102-12. PubMed ID: 19853461
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.
Kirkitadze MD; Kowalska A
Acta Biochim Pol; 2005; 52(2):417-23. PubMed ID: 15933761
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of scyllo-inositol derivatives and their effects on amyloid beta peptide aggregation.
Sun Y; Zhang G; Hawkes CA; Shaw JE; McLaurin J; Nitz M
Bioorg Med Chem; 2008 Aug; 16(15):7177-84. PubMed ID: 18635362
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
Jiao Y; Yang P
J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
[TBL] [Abstract][Full Text] [Related]
20. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
